Dr. Maarten Van Hemelen
ActiveSummary
Dr. Maarten Van Hemelen has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €216k and a net result of €109k. Equity is growing by ~88.7% per year across the filed fiscal years. Its solvency ranks better than 68% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+1
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €20k at 30 days acceptable
Liquidity ample (current ratio 4.63 against 3.68 in 2024; short-term debt: 21.1% and cash: 85.8% of total assets), and 21.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
78.9%
Return on assets
40%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-04-2026, 99 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
99 d early
2024
on the day
2023
56 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€216k▲ 103%
2024 · €106k
2023: €27k
2024: €106k
2023 → 2025
Total assets
€274k▲ 90.2%
2024 · €144k
2023: €36k
2024: €144k
2023 → 2025
Net result
€109k▲ 22.5%
2024 · €89k
2023: €23k
2024: €89k
2023 → 2025
Working capital
€210k▲ 109%
2024 · €100k
2023: €25k
2024: €100k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€27k-€106k▲ 293%€216k▲ 103%
Operating result€29k-€113k▲ 292%€140k▲ 24.0%
Net result€23k-€89k▲ 287%€109k▲ 22.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 24% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €274k
Fixed assets
€6k ▲ 39.8%
Current assets
€268k ▲ 94.2%
Equity and liabilities €274k
Equity
€216k ▲ 103%
Debt
€58k ▲ 54.3%
Debt's share of the balance-sheet total falls from 26.0% to 21.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€144k▲
2024 · €116k
Cash flow
€113k▲
2024 · €93k
Current ratio
4.63▲
2024 · 3.68
Debt to equity
0.27▼
2024 · 0.35
ROE
50.7%▼
2024 · 84.0%
ROA
40.0%▼
2024 · 62.1%
Interest coverage
2192.11▲
2024 · 1662.35
Debt ≤ 1 year
€58k▲
2024 · €37k
Income taxes
€31k▲
2024 · €24k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet
Code20242025
Assets
Total assets20/58€144k€274k▲
Formation expenses20€2k€0▼
Fixed assets21/28€4k€6k▲
Tangible fixed assets22/27€4k€6k▲
Furniture and vehicles24€4k€6k▲
Current assets29/58€138k€268k▲
Amounts receivable within one year40/41€1k€0▼
Trade receivables40€1k€0▼
Cash at bank and in hand54/58€126k€235k▲
Deferred charges and accrued income490/1€11k€33k▲
Equity and liabilities
Total equity and liabilities10/49€144k€274k▲
Equity10/15€106k€216k▲
Contributions10/11€4k€4k=
Reserves13€102k€212k▲
Distributable reserves133€102k€212k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€37k€58k▲
Amounts payable within one year42/48€37k€58k▲
Taxes, remuneration and social security45€26k€57k▲
Taxes450/3€26k€57k▲
Other amounts payable47/48€11k€450▼
Accrued charges and deferred income492/3€0-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€3k▲
Other operating charges640/8€868€866▼
Gross operating margin9900€117k€145k▲
Operating profit (loss)9901€113k€140k▲
Financial charges65/66B€70€66▼
Recurring financial charges65€70€66▼
Profit (loss) for the period before taxes9903€113k€140k▲
Income taxes67/77€24k€31k▲
Profit (loss) for the period9904€89k€109k▲
Profit (loss) for the period to be appropriated9905€89k€109k▲
Appropriation of the result
Profit (loss) to be appropriated9906€89k€109k▲
Transfer to equity691/2€79k€109k▲
To other reserves6921€79k€109k▲
Profit to be distributed694/7€10k€0▼
Return on contributions (dividend)694€10k€0▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €109k ▲22.5%
Operating result €140k, net result €109k, both a record.
31-12
Financial
Equity above €200kEq €216k ▲103%
3 profitable years in a row build equity to €216k.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €100kEq €106k ▲293%
2 profitable years in a row build equity to €106k.
05-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Katelijne-Waver · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waverstraat 352860 Sint-Katelijne-WaverGround area
2.1 ha
Building footprint
8,295 m²
Volume, LiDAR
9,965 m³
2 parcels, Flanders · tallest building 12.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ZNA CADIX
since 20232.348.158.281
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11807G2403/00A000 | Flanders | 1.9 ha | 1 · 8,100 m² | 12.3 m |
| 12035B0515/00B002 | Flanders | 1,178 m² | 1 · 194 m² | 10.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Cabinet Médical Drs TROISFONTAINES-de MARNEFFE
BE 0501.960.152
Liège · Eq €215,908
InfinitySight Clinic
BE 1006.296.212
Ukkel · Eq €215,957
Dr. L.S.A. Arnold
BE 0797.373.355
Gent · Eq €216,031
DIDARAD
BE 0762.511.357
Brussel · Eq €216,036
VDLELIE
BE 0791.467.738
Beersel · Eq €215,716
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,660 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded10-08-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
77225Rental and leasing activities
82300Organisation of conventions and trade shows
85592Vocational training
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.